- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 789-803 of
1,031 results
2008 Exhibit: Ex 2008 2018 01 25 Invalidity Contentions, Excerpted p 202
Document
IPR2018-01675, No. 2008-52 Exhibit - Ex 2008 2018 01 25 Invalidity Contentions, Excerpted p 202 (P.T.A.B. Jan. 3, 2019)
|
|
Cite Document
2010 Exhibit: Ex 2010 Amended Invalidity Contentions Ex C Excerpted
Document
IPR2018-01675, No. 2010-54 Exhibit - Ex 2010 Amended Invalidity Contentions Ex C Excerpted (P.T.A.B. Jan. 3, 2019)
|
|
Cite Document
2011 Exhibit: Ex 2011 20180813 Service of Sanofis Responses to Mylans Amende...
Document
IPR2018-01675, No. 2011-55 Exhibit - Ex 2011 20180813 Service of Sanofis Responses to Mylans Amended Contentions Redacted (P.T.A.B. Jan. 3, 2019)
|
|
Cite Document
2005 Exhibit: Ex 2005 Sanofi v Merck 2016 09 16 Complaint DI 1
Document
IPR2018-01675, No. 2005-49 Exhibit - Ex 2005 Sanofi v Merck 2016 09 16 Complaint DI 1 (P.T.A.B. Jan. 3, 2019)
|
|
Cite Document
2006 Exhibit: Ex 2006 DI 45 2018 02 05 Letter enclosing stip of Dismissal for Mylan
Document
IPR2018-01675, No. 2006-50 Exhibit - Ex 2006 DI 45 2018 02 05 Letter enclosing stip of Dismissal for Mylan (P.T.A.B. Jan. 3, 2019)
|
|
Cite Document
2009 Exhibit: Ex 2009 m Invalidity Contentions Amended Cover Pleading All Patent...
Document
IPR2018-01675, No. 2009-53 Exhibit - Ex 2009 m Invalidity Contentions Amended Cover Pleading All Patents, Excerpted p 268 9 (P.T.A.B. Jan. 3, 2019)
|
|
Cite Document
2001 Exhibit: Ex 2001 20130213 press release
Document
IPR2018-01675, No. 2001-45 Exhibit - Ex 2001 20130213 press release (P.T.A.B. Jan. 3, 2019)
|
|
Cite Document
1118 Exhibit: Sanofi Aventis US LLC v Mylan GmbH, Case 217 cv 09105 SRC, slip o...
Document
IPR2018-01675, No. 1118-265 Exhibit - Sanofi Aventis US LLC v Mylan GmbH, Case 217 cv 09105 SRC, slip op DNJ entered Mar 9, 2020 collateral opinion on infringement and validity (P.T.A.B. M...
|
|
Cite Document
1059 Exhibit: M Eledrisi, et al, ¿¿¿Twice Daily Insulin Glargine for Patients with Uncon...
Document
IPR2018-01675, No. 1059-215 Exhibit - M Eledrisi, et al, ¿¿¿Twice Daily Insulin Glargine for Patients with Uncontrolled Type 2 Diabetes Mellitus, Journal of Clinical Translational Endocrinology 15 2...
|
|
Cite Document
1047 Exhibit: Marilyn R Graff, RN, CDE et al, ¿¿¿Assessment by Patients with Diabet...
Document
IPR2018-01675, No. 1047-203 Exhibit - Marilyn R Graff, RN, CDE et al, ¿¿¿Assessment by Patients with Diabetes Mellitus of Two Insulin Pen¿¿¿, Clinical Therapeutics, Vol 20, No 3, 1998, p486 196 ...
|
|
Cite Document
1079 Exhibit: US Patent 6,100,376, ¿¿¿A21, B30 Modified Insulin Derivatives having...
Document
IPR2018-01675, No. 1079-235 Exhibit - US Patent 6,100,376, ¿¿¿A21, B30 Modified Insulin Derivatives having An Altered Action Profile¿¿¿, M D¿¿rschug issued Aug 8, 2000 (P.T.A.B. Sep. 18, 2019...
|
|
Cite Document
1049 Exhibit: Curriculum Vitae of William Curtis Biggs, MD, FACE, ECNU
Document
IPR2018-01675, No. 1049-205 Exhibit - Curriculum Vitae of William Curtis Biggs, MD, FACE, ECNU (P.T.A.B. Sep. 18, 2019)
|
|
Cite Document
2203 Exhibit: US Total Marketing Expenditure of Long Acting Insulin Franchises
Document
IPR2018-01675, No. 2203-180 Exhibit - US Total Marketing Expenditure of Long Acting Insulin Franchises (P.T.A.B. Jun. 25, 2019)
|
|
Cite Document
2124 Exhibit: Stacey A Seggelke et al, Effect of Glargine Insulin Delivery Method P...
Document
IPR2018-01675, No. 2124-102 Exhibit - Stacey A Seggelke et al, Effect of Glargine Insulin Delivery Method Pen Device Versus VialSyringe on Glycemic Control and Patient Preferences in Patien...
|
|
Cite Document
2140 Exhibit: Riccardo Perfetti, Reusable and Disposable Insulin Pens for the Trea...
Document
IPR2018-01675, No. 2140-121 Exhibit - Riccardo Perfetti, Reusable and Disposable Insulin Pens for the Treatment of Diabetes Understanding the Global Differences in User Preference and an E...
|
|
Cite Document
